In up to 25% of all hospitalized patients, there may be some form of Deep Vein Thrombosis, which often remains clinically unapparent.
That’s a lot! One in four hospitalized patients are likely to have a Deep Vein Thrombosis, so it is important that caregivers and patients be well informed of risk factors, signs, treatment, and prevention!
Our goal is that this site will help nurses and patients alike understand: the mechanism of action, indications, contraindications, adverse effects, and interactions involved with each of these drug classes in the treatment and prevention of Deep Vein Thrombosis (DVT) and other venous thromboembolic events (VTE).
We ask that you leave a comment or question on our postings, and enjoy reading in the hopes that we have helped to determine which coagulation modifying drug would be most beneficial in your situation.
Please keep in mind the following potential risk factors of major bleeding! BEWARE!
Hepatic or renal disease
Ethanol use (history of alcohol abuse, worsening liver disease)
Malignancy (recent metastic cancer)
Older (>75)
Reduced platelet count/function (<75,000)
Re-bleeding (prior hospitalized bleeding)
Hypertension (uncontrolled)
Anemia (hematocrit <30 or hemoglobin <10 g/dL)
Genetic factors
Elevated risk of fall (& neuropsychiatric disease)
Stroke
For further reading and information, we refer you to these sites:
Plavix
http://www.plavix.com/Index.aspx
Heparin
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM112597
Lovenox
http://www.lovenox.com/consumer/default.aspx
Warfarin
http://www.warfarindosing.orghttp://nlm.nih.gov/medlineplus/druginfo/meds/a682277http://mybloodthinner.org/research
Abbokinase
http://www.abbokinase.com/
Drugs.com sites for each coagulation modifier
http://www.drugs.com/warfarin , http://www.drugs.com/heparin.html , http://www.drugs.com/plavix.html , http://www.drugs.com/lovenox.html , http://www.drugs.com/mtm/urokinase.html
Subscribe to:
Post Comments (Atom)
I think that the information provided was very informative. For some people who do not know what coagulation modifiers are often times do not know what type of signs to look for. Seems that the information presented here allows for patients and loved ones to get the information they need in order to become aware of the risk factors that are associated with this type problem. The author gave pertinent information that related to statistical data in how often this type of problem occurs on a daily basis and a percentage of patients that are affected. The patients are not the only ones affected but the ones who care for them. Gaining knowledgeable information helps to alleviate the fears often associated with the unknown. I gained valuable information from this presentation and will pass on the website to encourage others to get this valuable information that could be life saving to one your loved ones one day. Great job.
ReplyDeleteThank you for the up-to-date evidence based information. I plan to utilize this information with my clnical nursing students.
ReplyDeleteSara Washington, MS, RN